Pricing Log in Create free account

Apollomics Inc. (APLM) vs Cingulate Inc. (CING)

Apollomics Inc. and Cingulate Inc. are both Biotechnology companies. Apollomics Inc. and Cingulate Inc. are of similar size ($63.8M and $61.2M). Across the 7 metrics below, Apollomics Inc. leads on 6 and Cingulate Inc. on 1.

Valuation

Metric APLM CING Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m 2.43 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (0.28%) (82.91%) (33.15%)
Free cash flow yield 0.00% (36.67%) (25.50%)

Profitability

Metric APLM CING Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin — 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (198.74%) (56.36%)
Return on assets 0.00% (123.76%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APLM CING Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 85.66% 56.47% 30.26%
Revenue growth, 5-year CAGR 32.77% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APLM CING Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.96 3.50 4.72
Net debt to EBITDA 0.37 0.51 0.96

Dividend

Metric APLM CING Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric APLM CING Biotechnology median
Market cap 61.22m 63.84m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack